- A further $1,050,000, therefore $2.45 million in total, is anticipated provided that 100% of the unlisted options (priced at $0.06) are exercised (see further details below).
- ADD may at its discretion give notice and demand the Option Holder exercise their Options upon ADD reaching a 10 day VWAP above $0.12, which must occur within seven (7) days of receipt of said notice.
Very bullish T&Cs. With the options expiring in December 2021, ADD Mgmt have set themselves a short time frame to add value to both the company and its shareholders. No doubt they will be working hard to achieve the $0.12 VWAP (or 200% appreciation from the raising price) to enable them to call the options and add a further $mil to the kitty. This should give shareholders confidence that ADD will be incredibly prudent with the first $1.4m. Whilst those funds may not last a complete year, I'm quite certain it will get the share price beyond that 12c 10 day vwap target well before the options expire. Bullish and very favorable for all involved.
Well done.
- Forums
- ASX - By Stock
- Ann: Strategic Placement to Expedite Exploration and Drilling
- A further $1,050,000, therefore $2.45 million in total, is...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADD (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.326M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 9137000 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 8963277 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 9137000 | 0.004 |
16 | 11839589 | 0.003 |
10 | 6250000 | 0.002 |
6 | 10000000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 6963277 | 13 |
0.006 | 11843406 | 9 |
0.007 | 12409536 | 9 |
0.008 | 4372084 | 7 |
0.009 | 8652428 | 3 |
Last trade - 16.12pm 15/07/2024 (20 minute delay) ? |
Featured News
ADD (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online